Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor Meeting Abstract
| Authors: | Schram, A.; Borad, M.; Sahai, V.; Kamath, S.; Kim, R.; Liao, C. Y. A.; Oh, D. Y.; Ponz-Sarvisé, M.; Yachnin, J.; Shell, S. A.; Cassier, P.; Dotan, E.; Florou, V.; Moreno, V.; Park, J. O.; Tai, D.; Schmidt-Kittler, O.; Ferté, C.; Goyal, L.; Subbiah, V. |
| Abstract Title: | Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor |
| Meeting Title: | 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 174 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Oct 26-28 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S116 |
| Language: | English |
| DOI: | 10.1016/s0959-8049(22)01110-8 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 326 (PB106) -- In Poster Session: Molecular Profiling -- Source: Cinahl |
